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Introduction 86 87 Glaucoma is a diverse set of diseases with heterogeneous phenotypic presentations. 88
Untreated, glaucoma leads to permanent damage of axons in the optic nerve and visual 89 field loss. Millions of people worldwide are affected (Quigley, 1996; Thylefors and 90 Negrel, 1994) , and in the United States glaucoma is the second leading cause of 91 blindness (Leske, 1983) . Adult-onset glaucoma is associated with multiple risk factors 92 such as intraocular pressure (IOP), age, family history, ethnicity, central corneal 93 thickness and axial length (Aboobakar et al., 2016; Liu and Allingham, 2011; Nickells, 94 2012; Springelkamp et al., 2017) . Genetically, primary open angle glaucoma (POAG) 95 and normal tension glaucoma (NTG), common forms of adult-onset glaucoma, are 96 currently associated with 16 loci (Wiggs and Pasquale, 2017) and exhibit complex 97 inheritance. The present set of POAG genetic risk factors explains only 3-6% of the 98 genetic variance (Verma et al., 2016) . Thus, fully defining the genetic basis of glaucoma 99 will require advances in analytical approaches and experimental methods (Boyle et al., 100 2017) . 101 102 Many investigators have turned to mouse models to identify causal events linking 103 glaucomatous risk factors and the death of retinal ganglion cells (Struebing and Geisert, 104 2015) . Compelled by the genetic simplicity that recombinant inbred (RI) mouse strains 105 afford in mapping genotype to phenotype (Geisert et al., 2009 ), we designed a study 106 investigating the variance of axon loss due to increased IOP in a large cohort of mice. 107
For this purpose, we used the BXD RI strain set, which is particularly suited for the 108 study of genetics and the effects on the severity of glaucoma. This genetic reference 109 panel presently consists of over 200 strains. The original 36 strains were extensively 110 studied by our group for more than 18 years. Over the last decade, the Williams group 111 has greatly expanded the BXD family. Both parental strains (C57BL/6J and DBA/2J) are 112 completely sequenced, and all BXD strains are fully mapped with more than 17,000 113 genetic markers. As a result, the current set of BXD strains is far larger than any other 114 mature RI resource and allows for sub-megabase resolution QTL mapping. 6 including numerous ocular phenotypes (RGC number, IOP, eye size, retinal area, etc.), 117 global transcriptome data for the eye (HEIMED (Geisert et al., 2009) ) and retina (HEI 118 Normal Retina Database (Freeman et al., 2011 ), DoD Normal Retina database (King et 119 al., 2015 ), and experimental consequences of optic nerve crush (ONC Retina 120 Database (Templeton et al., 2013) ) along with the effects of blast injury (DoD Blast 121 Dataset (Struebing et al., 2017) ). Each data set consists of measurements for as many 122 as 80 strains, making the BXD set extremely revealing in the analysis of QTLs and 123 ocular disease networks. 124
125
Because we needed a consistent and predictable model to increase IOP with little 126 technical variation, we have adopted a method developed by Samsel et al. (Samsel et 127 al., 2010) to induce acute IOP elevation through the injection of magnetic microspheres 128 and the migration of these microspheres into the trabecular meshwork using magnetic 129 fields. This method of blocking the trabecular meshwork yields a reliable IOP increase, 130 and allows us to define BXD strains with differing susceptibility to axon loss. We then 131 use these data to define a genomic locus modulating axon loss across the BXD strains. 132 133 Methods 134
Animals 135
All animals used in this study were either bought from the Jackson laboratory (Bar 136 Harbor, ME) or bred in-house in a parasite-free facility. All mice were between 60 and 137 100 days of age and maintained on a 12h light -12h dark cycle with food and water ad 138 libitum. All procedures involving animals were approved by the Animal Care and Use 139
Committee of Emory University and were in accordance with the ARVO Statement for 140 the Use of Animals in Ophthalmic and Vision Research. 141 142
Microsphere Injection and Elevation of IOP 143
To define the effect of elevated IOP on retinal ganglion cell loss, we examined axonal 144 loss in 47 BXD RI strains. A total of 230 mice received an injection of magnetic 7 microspheres into the right eye, following a method developed by Samsel et al. (Samsel 146 et al., 2010) . Briefly, magnetic microbeads (Spherotech PM-40-10) with a diameter of 147 4.14µm were washed in sterile HBSS 3 times and diluted 3-fold. The animals were 148 deeply anesthetized with Ketamine (100mg/kg) and Xylazine (15mg/kg) and 10-15 µL of 149 microbead solution were slowly injected into the anterior chamber with a custom-made 150 30G needle. The needle was held in place while microspheres were pulled into the 151 trabecular meshwork with the help of a handheld 0.5T magnet. After having selectively 152 fixed the magnetic microbeads in the iridocorneal angle, the needle was retracted and 153 carrier HBSS was allowed to drain from the anterior chamber. After the end of the 154 surgery, a drop of topical antibiotic (Certi-Sporyn Neomycin sulfate) was applied to the 155 cornea and mice were allowed to recover on a heating pad until fully awake. Left eyes 156 of many animals served as non-injected controls, but were excluded when any axon 157 damage was present. A total of 181 control eyes and 191 bead injected eyes were 158 included in the study. 159
160

IOP Measurement 161
We measured IOP before the injection of magnetic microspheres to establish baseline 162 values, and then at 2d, 4d, 7d, 9d, 14d, and 21d after the surgery. including DBA/2J (Nagaraju et al., 2007; Saleh et al., 2007) . The visual axis of the 168 injected eyes remained clear with no visible signs of inflammation. For a bead-injected 169 eye to be included in the sample set, the IOP had to be above 25 mmHg in two 170 consecutive measurements or above 30 mmHg in a single measurement. Bead injected 171 eyes that did not meet this minimum criterion were excluded from the analysis. 172 by 2% paraformaldehyde and 2% glutaraldehyde in phosphate buffer (pH 7.4). The 177 optic nerves were carefully dissected and post-fixed for 24 hours at 4°C. Nerves were 178 dehydrated and embedded in plastic (Libby et al., 2005) . Thin sections (0.7µm) were cut 179 from each nerve and mounted on glass slides. Sections were stained using a modified 180 paraphenylenediamine (PPD) staining protocol. Slides were photographed using an 181
Olympus BX51 microscope and a Microfire camera (Optronix) at a final magnification of 182 1,200X. Healthy axons were counted using ImagePad software developed in our 183 laboratory for the iPad as described previously (Templeton et al., 2014) . To assure that 184 all sections were sampled systematically, a grid overlay was placed on the image of the 185 optic nerve and fields were counted every 10 cells along appropriately spaced rows. 186
This resulted in a minimum of 20 fields evenly spaced across the optic nerve, assuring 187 that all sectors of the nerve were included in our sample. The sample was then 188 converted to the average number of axons per mm 2 . The cross-sectional area of the 189 section through the optic nerve was calculated from a low power photomicrograph using 190 NIH ImageJ. These two measures were then used to provide an accurate estimate of 191 the axons within each optic nerve. 192
193
Analysis of Axon Loss 194
To map the genomic loci modulating axon loss, we calculated the average number of 195 axons per strain in the normal nerves and the average number of axons in each strain 196 following elevated IOP. We then subtracted the average number of axons in the bead 197 injected nerves from that of the normal nerves to define the axon loss for each strain. new sequence data to restrict analysis to those parts of the QTL that are not identical-205 by-descent between the parental strains; 3) identification and analysis of all 206 polymorphisms, including SNPs, InDels, inversions, and CNVs in the QTL interval using 207 D2 genome sequence and the reference genome sequence of B6; 4) identification of 208 genes whose expression is high in the eye, retina, or other ocular tissue; 5) correlation 209 between our phenotype data and gene expression data from the eye and/or retina to 210 extract highly correlated genes in the QTL; and 6) gene analysis from the literature and 211
other external data resources. The IOP was elevated in 49 strains of mice by injection of magnetic beads into the 262 anterior chamber and fixation thereof in the trabecular meshwork with a hand-held 263 magnet (Samsel et al., 2010) . In all cases, the right eye was injected, while the left eye 264 11 served as control except in a few cases where the left optic nerve contained damaged 265 axons. Following the injection, IOP was measured in both eyes over the next 21 days. 266
The IOP in the injected eye rose quickly to glaucomatous levels (typically defined by > 267 20mmHg in humans) and remained elevated for the duration of this experiment (Fig. 1) . 268
Thus, this method proved to be a reliable approach to acutely elevate IOP in the mouse 269 eye, even though it was originally developed for the rat (Samsel et al., 2011) . 270
271
The first step in the analysis was to generate a series of measures for the normal 272 control eyes. After appropriate fixation and preparation of the optic nerve for 273 microscopy, normal axons were quantified for 181 eyes in 49 strains. (Fig. 2, right  274 panel). The number of axons ranged from a mean of 37,2277 axons in BXD36 to a 275 mean of 78,159 in BXD97. The average number of axons per eye was 54,788 with a 276 standard deviation of 8,622, demonstrating natural variation in the number of optic 277 nerve axons across the BXD strain set. There was a significant difference between the 278 strain with the highest and the lowest number of axons within the optic nerve (p = 0.002, 279
Mann-Whitney U test). 280
281
When the IOP was artificially elevated, the average axon number decreased across the 282 49 strains to 49,545 axons per optic nerve with a standard error of 9,982 axons ( Fig.  283   2b) . Thus, elevation of IOP decreased the average number of axons in the optic nerve, 284 while it increased the standard deviation. Within the bead injected eyes, axon number 285 ranged from 29,720 axons in the lowest strain (BXD1) to 72,473 axons in the highest 286 strain (BXD97). The difference between the lowest and highest strain was significant 287 (p=0.018, Mann-Whitney U test). When the number of axons in the normal retina and 288 the number of axons following elevated IOP were used to generate genome-wide 289 interval maps, they both revealed the same suggestive quantitative trait loci (QTLs) on 290 proximal chromosome 3 (Fig. 3) . Neither dataset had QTLs that reached the 291 significance level (p > 0.05). 292
12
To define genomic loci that could modulate the susceptibility of RGCs to death, axon 294 loss per strain was calculated by subtracting the mean number of axons in the bead 295 injected eyes from the mean number of axons in the normal eyes for each strain (Fig.  296   4) . The eye with elevated IOP had an average axon loss of 9.6% relative to the non-297 injected control eye. There was considerable variability in axon loss across the 49 298 strains ranging from basically no axon loss in several strains to an average loss of 299 20,000 axons in BXD1 and BXD51. These data were used to generate a genome-wide 300 interval map (Fig. 5) , which revealed a suggestive QTL on chromosome 9 and a 301 significant QTL on chromosome 18. The significant peak on chromosome 18 (Fig. 6 ) 302 was found between two genomic markers, rs13483369 (54.614840 Mb, mm10) and 303 rs215803889 (56.037647 Mb). Because the high BXD genotyping density with >17,000 304 segregating markers allows us to map with a precision of roughly ±1 Mb, we examined 305 the region on chromosome 18 from 53.6 to 57 Mb to define potential candidate genes 306 modulating axonal loss. Good candidates should either contain nonsynonymous SNPs 307 altering their amino acid sequence, or they should be cis-eQTLs, meaning that their 308 expression level segregates into two groups defined by the distribution of parental 309 alleles (Struebing et al., 2016) . Examining the sequences between B6 and D2 using the 310 SNP browser on GeneNetwork did not reveal genes with nonsynonymous SNPs within 311 this 2 Mb large region. We then queried our recently published BXD Normal Retina 312 databases on GeneNetwork for cis-eQTLs (DoD Normal Retina Affy MoGene 2.0 ST 313 (May 15) RMA Gene Level, (King et al., 2015) ). Only one known gene, Aldh7a1, 314 showed a significant LRS score (p < 0.01, Probe 17354434), suggesting that this gene 315 is a single cis-eQTL within this interval. The differential expression between C57BL/6J 316 and DBA/2J parents was then confirmed by quantitative PCR (p = 0.028, Wilcoxon rank-317 sum test, Supplemental Fig. 1) . 318
319
We then examined the distribution of ALDH7A1 in the retina using 320 immunohistochemical methods. We stained retinal sections or flat-mounts with 321 antibodies against ALDH7A1 and the RGC markers TUJ1 or RBPMS ( Figure 6 ). While 322 TUJ1 is known to stain RGCs and a few other retinal neurons as well as axons, RBPMS 323 expression was shown to be restricted to the RGC population (Rodriguez et al., 2014; 324 while ALDH7A1 staining was also present throughout other retinal layers, including 326 cone photoreceptors. Higher magnifications revealed that ALDH7A1 staining was 327 relatively ubiquitous in cell body and axons but absent from the nucleus. These results 328 are in line with other studies that have demonstrated mitochondrial and cytosolic 329 localization of ALDH7A1 in humans and rodents (Brocker et al., 2011; Brocker et al., 330 2010; Wong et al., 2010) . 331
In order to test whether variants in ALDH7A1 influence primary open-angle glaucoma 332 (POAG) susceptibility in humans, we interrogated results from the NEIGHBORHOOD 333 GWAS glaucoma dataset from 3,853 cases and 33,480 controls in the human genomic 334 region corresponding to the mouse ALDH7A1 locus. The intronic variant rs62391530 335 showed the strongest relation to POAG with a nominal p-value of 0.02 and an effect 336 size of -0.16. Even though ALDH7A1 variants did not reach the genome-wide 337 significance threshold of 5x10 -8 , this gene is part of the KEGG "butanoate metabolic 338 pathway", which was previously identified to be associated with both POAG and NTG 339 (Bailey et al., 2014) . 340 341
Discussion 342
Earlier work in glaucoma suggested a role for genetic background in the degeneration of 343
RGCs. The best evidence for this comes from studies in inbred mice (Li et al., 2007) . 344
For example, Li et al. looked at the loss of retinal ganglion cells after optic nerve crush 345 in 15 different inbred mouse strains. There was a considerable variability in ganglion cell 346 loss among different strains, and the authors showed that this difference was heritable. 347
In another study, Anderson et al. found that transferring the two known glaucoma-348 causing DBA/2J mutations onto a C57BL/6J wild-type background recapitulated the iris 349 pigment disease without causing IOP elevation or a neurodegenerative optic nerve 350 phenotype (Anderson et al., 2006) . These studies clearly demonstrate a heritable 351 component in the susceptibility of RGCs to cell death. 352 14 mapping for this trait, we could identify a significant genomic interval on Chromosome 18, 356 which likely modified axon loss. We only found one candidate gene within this locus, and we 357 were able to confirm differential expression of this gene, Aldh7a1, between the B6 and D2 358
parents. Furthermore, immunohistochemistry demonstrated expression of ALDH7A1 protein 359 in RGC somata and axons, consistent with its hypothesized role of influencing RGC death 360 susceptibility. 361 362 Aldehyde dehydrogenase 7 family member 1 (ALDH7A1), also known as antiquitin, is an 363 enzyme involved in lysine metabolism and protection of cells from hyperosmotic stress 364 (Brocker et al., 2011; Brocker et al., 2010) . Mutations in Aldh7a1 are most prominently known 365 to cause pyridoxine-dependent seizures, a very rare neurological disease characterized by 366 intractable pre-and neonatal seizures that can be treated with large daily doses of Vitamin 367 B6 (Mills et al., 2006) . A lower concentration of ALDH7A1 mRNA and protein was also 368 previously found in the brain of DBA/2J mice compared to C57Bl/6J mice, which is coherent 369 with our results and suggests that this QTL is not only retina-specific (Bhave et al., 2006) . 370 371 While GWAS have identified many genes associated with glaucoma risk, a recent analysis 372 (Bailey et al., 2014) used a randomized analysis to take the single gene data and assign 373 associated molecular pathways. One pathway involved butanoate metabolism (KEGG 374 pathway hsa00650; see Figure 3 in (Bailey et al., 2014) ). This pathway is associated 375 with both POAG (8 genes with nominal association) and NTG (8 genes with nominal 376 associations) Of the 5 enzymes (ALDH1B1, ALDH2, ALDH3A2 ALDH7A1 and 377 ALDH9A1) associated with the conversion of Acetaldehyde to Acetyl-CoA, three 378 (ALDH1B1, ALDH2 and ALDH3A2) have a nominal association with either POAG or 379 NTG. Even though ALDH7A1 does not have a significant association with human 380 glaucoma, it is a participant in a molecular pathway that is directly involved in POAG 381 and NTG risk. 382
383
Since we used an inducible glaucoma model in this study, additional factors may have 384 influenced our mapping results. For example, the scleral stiffness (compliance) may be 385 different between BXD strains, which could lead to differential susceptibility to artificial IOP 386 15 elevation (Sigal and Ethier, 2009 ). Likewise, differences may exist in the clearance of 387 magnetic beads from the iridocorneal angle. An interesting possibility for the difference in 388 axon loss we have demonstrated in the BXD strain set is differential susceptibility of RGC 389 subtypes to IOP elevation. It was previously shown that alpha-RGCs and melanopsin-390
containing RGCs were more resistant to axotomy-induced cell death (Duan et al., 2015; 391 Struebing et al., 2016) , and similar observations were made in a mouse model of chronically 392 elevated IOP (Feng et al., 2013) . These findings argue for the existence of distinct 393 transcriptional programs within each RGC subtype (Struebing et al., 2016) . Further 394 developments in this area of research will certainly shed more light onto the molecular 395 mechanisms leading to differential susceptibility of RGCs to death. 396
397
In summary, the present study examined the loss of RGCs following an elevation of IOP in 398 the BXD mouse strain set. We identified a single locus on Chr. 18 that modulates the loss of 399 indicates the total likelihood ratio statistic (LRS) score as specified on the y-axis. The 559 red line illustrates the contribution from the B6 allele and the green line the contribution 560
from the D2 allele. The location across the genome is indicated on the top from 561 chromosome 1 to chromosome X. Notice one suggestive QTL peak on Chr3 (exceeding 562 the gray line, p<0.63). 563 564 566 567 Figure 4 : The average axon loss per strain is given in (A) in decreasing order. The 568 genome-wide interval map is shown in (B). Here, chromosomes are displayed on the X 569 axis, while the LRS score is plotted in blue along the Y axis. The light red line defines 570 the genome-wide QTL significance interval of p < 0.05, while the light grey line identifies 571 a suggestive QTL. Notice one significant LRS peak on chromosome 18 and one 572
suggestive QTL on chromosome 9. 573 574 23 575 576 577 578 Figure 5 . Map of gene locations across Chr. 18. The haplotype map for the 47 strains in 579 the axon loss dataset is shown in the top panel. The haplotype map displays the 580 contribution of each of the two parental strains. The red represents the B6 alleles, green 581 defines the D2 alleles, blue represents regions of the DNA that are heterozygotic and 582 gray is unmapped. At the far right is a list of the specific BXD RI strains with the 583 associated axon loss in decreasing order from top to bottom. The QTL significance is 584 indicated by the blueline below the haplotype map. A positive additive coefficient (red 585 line) indicates that B6 alleles are associated with higher trait values. The QTL reaches 586 significance from ~56 to ~58 Mb (p<0.05, light red line). 587 588
